Recent cancer survival in Germany: An analysis of common and less common cancers

International Journal of Cancer

Volumn 136, Issue 11, 2015, Pages 2649-2658

  Jansen, Lina ^a   Castro, Felipe A ^a   Gondos, Adam ^a   Krilaviciute, Agne ^a   Barnes, Benjamin ^b   Eberle, Andrea ^c   Emrich, Katharina ^d   Hentschel, Stefan ^e   Holleczek, Bernd ^f   Katalinic, Alexander ^g   Brenner, Hermann ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c LEIBNIZ INSTITUTE FOR PREVENTION RESEARCH AND EPIDEMIOLOGY BIPS   (Germany)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^e Border Inspection Post Hamburg Harbour   (Germany)

^f Saarland Cancer Registry   (Germany)

^g UNIVERSITY OF LÜBECK   (Germany)

Author keywords

cancer registry; cancer survival; Germany; period analysis

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER REGISTRY; CANCER SURVIVAL; COLORECTAL CANCER; FEMALE; GERMAN (CITIZEN); GERMANY; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; OVARY CANCER; PHARYNX CANCER; PRIORITY JOURNAL; PROSTATE CANCER; SURVIVAL TIME; THYROID CANCER; TREND STUDY; UTERINE CERVIX CANCER; COMPARATIVE STUDY; EPIDEMIOLOGY; MORTALITY; NEOPLASM; PATHOLOGY; REGISTER; STATISTICS AND NUMERICAL DATA; SURVIVAL; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; GERMANY; HUMANS; NEOPLASMS; REGISTRIES; SURVIVAL ANALYSIS; UNITED STATES;

EID: 84924911594     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29316     Document Type: Article

References (41)

1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer. Available from: http://globocan.iarc.fr. Accessed on April 17, 2014.
2. American Cancer Society. Global cancer facts and figures, 2nd edn. Atlanta: American Cancer Society, 2011.
3. Rachet B, Ellis L, Maringe C, et al. Socioeconomic inequalities in cancer survival in England after the NHS cancer plan. Br J Cancer 2010; 103: 446-53.
4. Gatta G, Trama A, Capocaccia R,. Variations in cancer survival and patterns of care across Europe: roles of wealth and health-care organization. J Natl Cancer Inst Monogr 2013; 2013: 79-87.
5. Oberaigner W, Minicozzi P, Bielska-Lasota M, et al. Survival for ovarian cancer in Europe: the across-country variation did not shrink in the past decade. Acta Oncol 2012; 51: 441-53.
6. Hiripi E, Gondos A, Emrich K, et al. Survival from common and rare cancers in Germany in the early 21st century. Ann Oncol 2012; 23: 472-9.
7. Jansen L, Gondos A, Eberle A, et al. Cancer survival in Eastern and Western Germany after the fall of the iron curtain. Eur J Epidemiol 2012; 27: 689-93.
8. Jansen L, Eberle A, Emrich K, et al. Socio-economic deprivation and cancer survival in Germany: an ecological analysis in 200 districts in Germany. Int J Cancer 2014; 134: 2951-60.
9. Majek O, Gondos A, Jansen L, et al. Survival from colorectal cancer in Germany in the early 21st century. Br J Cancer 2012; 106: 1875-80.
10. Gondos A, Hiripi E, Holleczek B, et al. Survival among adolescents and young adults with cancer in Germany and the United States: an international comparison. Int J Cancer 2013; 133: 2207-15.
11. Brenner H, Jansen L,. Determinants and interpretation of death certificate only proportions in the initial years of newly established cancer registries. Eur J Cancer 2013; 49: 931-7.
12. De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5: a population-based study. Lancet Oncol 2014; 15: 23-34.
13. Surveillance, Epidemiology, and End Results (SEER) Program. Research data (1973-2010). National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch; 2013. Available from: www.seer.cancer.gov.
14. Corazziari I, Quinn M, Capocaccia R,. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004; 40: 2307-16.
15. Brenner H, Gefeller O,. An alternative approach to monitoring cancer patient survival. Cancer 1996; 78: 2004-10.
16. Brenner H, Hakulinen T,. Up-to-date long-term survival curves of patients with cancer by period analysis. J Clin Oncol 2002; 20: 826-32.
17. Henson DE, Ries LA,. The relative survival rate. Cancer 1995; 76: 1687-8.
18. Ederer F, Heise H,. Instructions to IBM 650 programmers in processing survival computations. Bethesda, MD: National Cancer Institute, 1959.
19. Center for Disease Control and Prevention. Publications and information products life tables. Available from: http://www.cdc.gov/nchs/products/life-tables.htm. Accessed on February 06, 2014.
20. Brenner H, Hakulinen T,. Up-to-date and precise estimates of cancer patient survival: model-based period analysis. Am J Epidemiol 2006; 164: 689-96.
21. Brenner H, Holleczek B,. Deriving valid population-based cancer survival estimates in the presence of nonnegligible proportions of cancers notified by death certificates only. Cancer Epidemiol Biomarkers Prev 2011; 20: 2480-6.
22. Brenner H, Gefeller O, Hakulinen T,. A computer program for period analysis of cancer patient survival. Eur J Cancer 2002; 38: 690-5.
23. National Center for Health Statistics. Health, United States, 2012: with special feature on emergency care. Hyattsville, MD: National Center for Health Statistics, 2013.
24. Dreier M, Borutta B, Toppich J, et al. Mammography and cervical cancer screening-a systematic review about women's knowledge, attitudes and participation in Germany. Gesundheitswesen 2012; 74: 722-35.
25. Sirovich BE, Schwartz LM, Woloshin S,. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? JAMA 2003; 289: 1414-20.
26. Becker N,. Epidemiological aspects of cancer screening in Germany. J Cancer Res Clin Oncol 2003; 129: 691-702.
27. Stock C, Haug U, Brenner H,. Population-based prevalence estimates of history of colonoscopy or sigmoidoscopy: review and analysis of recent trends. Gastrointest Endosc 2010; 71: 366.e2-381.e2.
28. Morris LG, Sikora AG, Tosteson TD, et al. The increasing incidence of thyroid cancer: the influence of access to care. Thyroid 2013; 23: 885-91.
29. Hall SF, Irish J, Groome P, et al. Access, excess, and overdiagnosis: the case for thyroid cancer. Cancer Med 2014; 3: 154-61.
30. SEER Fast Stats. Available from: http://seer.cancer.gov/faststats/. Accessed on July 18, 2014.
31. Robert Koch Institute. German Centre for Cancer Registry Data, Database Query. Available from: http://www.krebsdaten.de/database. Accessed July 18, 2014.
32. Gondos A, Holleczek B, Arndt V, et al. Trends in population-based cancer survival in Germany: to what extent does progress reach older patients? Ann Oncol 2007; 18: 1253-9.
33. Janssen-Heijnen ML, Houterman S, Lemmens VE, et al. Age and co-morbidity in cancer patients: a population-based approach. Cancer Treat Res 2005; 124: 89-107.
34. Foster JA, Salinas GD, Mansell D, et al. How does older age influence oncologists' cancer management? Oncologist 2010; 15: 584-92.
35. Coiffier B,. Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphoma. Semin Oncol 2002; 29: 18-22.
36. Forstpointner R, Dreyling M, Repp R, et al. The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. Blood 2004; 104: 3064-71.
37. Kumar SK, Rajkumar SV, Dispenzieri A, et al. Improved survival in multiple myeloma and the impact of novel therapies. Blood 2008; 111: 2516-20.
38. Boyd C, Zhang-Salomons JY, Groome PA, et al. Associations between community income and cancer survival in Ontario, Canada, and the United States. J Clin Oncol 1999; 17: 2244-55.
39. Weir HK, Johnson CJ, Thompson TD,. The effect of multiple primary rules on population-based cancer survival. Cancer Causes Control 2013; 24: 1231-42.
40. Holleczek B, Brenner H,. Reduction of population-based cancer survival estimates by trace back of death certificate notifications: an empirical illustration. Eur J Cancer 2012; 48: 797-804.
41. Woods LM, Rachet B, Ellis L, et al. Full dates (day, month, year) should be used in population-based cancer survival studies. Int J Cancer 2012; 131: E1120-E1124.